MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

09 Feb 2022 Evaluate
The sales declined to Rs. 179.53 millions for the December 2021 quarter as compared to Rs. 209.12 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 24.74  millions from Rs. 30.04 millions ,decline by -17.64%.The company reported a degrowth in operating Profit to 33.78 millions from 40.83 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 179.53 209.12 -14.15 806.45 642.74 25.47 868.71 456.33 90.37
Other Income 4.53 -2.20 -305.91 16.77 17.67 -5.09 18.10 5.95 204.20
PBIDT 33.78 40.83 -17.27 148.35 161.00 -7.86 206.98 92.73 123.21
Interest 0.23 0.00 0.00 0.40 0.00 0.00 0.13 0.00 0.00
PBDT 33.55 40.83 -17.83 147.95 161.00 -8.11 206.85 92.73 123.07
Depreciation 0.79 0.26 203.85 1.72 0.63 173.02 0.88 0.08 1000.00
PBT 32.76 40.57 -19.25 146.23 160.37 -8.82 205.97 92.65 122.31
TAX 8.02 10.53 -23.84 36.80 40.63 -9.43 54.64 27.70 97.26
Deferred Tax 0.03 -0.01 -400.00 0.24 0.03 700.00 0.04 0.04 0.00
PAT 24.74 30.04 -17.64 109.43 119.74 -8.61 151.33 64.95 132.99
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 18.82 19.52 -3.63 18.40 25.05 -26.56 23.83 20.32 17.25
Peers